Aurobindo Pharma USA Inc. recalls Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
Superpotent and Failed Tablet/Capsule Specifications
Read the official notice →- Date
- 2022-02-02
- Country
- United States
- Brand
- Aurobindo Pharma
- Product
- Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
- Classification
- Class II
- Units
- Nationwide in the US
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Aurobindo Pharma recalls
- 2023-08-30
USAurobindo Pharma USA Inc. recalls Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279…
cGMP deviations: Batch was released prior to approval.
- 2023-05-31
- US
Aurobindo Pharma USA Inc. recalls Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardboard carton, Distributed by: Walgreen Co., 200…
Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.
FDA · DrugAurobindo Pharma USA Inc.The recalled product was distributed to one Retail Distributor (Walgreens) who…Official notice → - 2022-11-02
- US
Aurobindo Pharma USA Inc. recalls Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, Inc. 279…
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
- 2022-04-20
- US
Aurobindo Pharma USA Inc. recalls Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics…
Subpotent Drug: Out of Specification results for Assay
- 2022-02-23
- US
Aurobindo Pharma USA Inc. recalls Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East…
Failed Impurities/Degradation Specifications
- 2021-12-01
- US
Aurobindo Pharma USA Inc. recalls Carvedilol Tablets, USP, 6.25 mg, 500 Tablets bottle, Rx Only, Distributed by: Aurobindo Pharma USA Inc., 279 Princeton-Hightstown…
Failed Impurities/Degradation Specifications
Other drugs & medical recalls in the United States
- 2022-02-02
- US
Dental Alliance Holdings LLC recalls CTx7 Kit, contains one tube CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 oz (57 g) Rx only NDC: 61578-205-01…
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
FDA · DrugDental Alliance Holdings LLCDistributed nationwide with the United StatesOfficial notice → - US
Mylan Pharmaceuticals Inc recalls Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only,…
cGMP deficiencies
FDA · DrugMylan Pharmaceuticals IncRecalled product was distributed nationwide within the United States.Official notice → - US
- US
- US
- US